Structural optimization elaborates novel potent Akt inhibitors with promising anticancer activity
Author:
Funder
National Natural Science Foundation of China
Shandong Science and Technology
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference24 articles.
1. AKT signaling in normal and malignant cells;Testa;Oncogene,2005
2. Targeting PI3K/Akt/mTOR signaling in cancer;Porta;Front. Oncol.,2014
3. PI3K/AKT signaling pathway and cancer: an updated review;Martini;Ann. Med.,2014
4. Developments in selective small molecule ATP-targeting the serine/threonine kinase Akt/PKB;Wang;Mini Rev. Med. Chem.,2011
5. Design, synthesis and evaluation of novel indole derivatives as AKT inhibitors;Yang;Bioorg. Med. Chem.,2014
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design and Synthesis of Polyheterocyclic Compounds Containing Pyrazolopyridopyrimidine Nucleus with Antimicrobial Activities;ChemistryOpen;2024-04-29
2. The mechanism of anticancer effects of some pyrrolopyrimidine derivatives on HT-29 human colon cancer cells;Toxicology in Vitro;2024-03
3. Discovery of novel Akt1 inhibitors by an ensemble-based virtual screening method, molecular dynamics simulation, and in vitro biological activity testing;Molecular Diversity;2024-01-19
4. Synthesis of ferrocenyl benzimidazole derivatives as novel anti-Toxoplasma gondii agents;New Journal of Chemistry;2024
5. The Application of Pyrrolo[2, 3-d]pyrimidine Scaffold in Medicinal Chemistry from 2017 to 2021;Mini-Reviews in Medicinal Chemistry;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3